Attached files

file filename
EX-31.2 - EX-31.2 - Orthofix Medical Inc.ofix-ex312_16.htm
EX-31.1 - EX-31.1 - Orthofix Medical Inc.ofix-ex311_17.htm
EX-23.1 - EX-23.1 - Orthofix Medical Inc.ofix-ex231_11.htm
EX-21.1 - EX-21.1 - Orthofix Medical Inc.ofix-ex211_10.htm
EX-10.12 - EX-10.12 - Orthofix Medical Inc.ofix-ex1012_33.htm
EX-10.10 - EX-10.10 - Orthofix Medical Inc.ofix-ex1010_422.htm
EX-10.3 - EX-10.3 - Orthofix Medical Inc.ofix-ex103_34.htm
10-K - 10-K - Orthofix Medical Inc.ofix-10k_20171231.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Orthofix International N.V. (“Orthofix”) on Form 10-K for the period ended December 31, 2017, (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, Bradley R. Mason, Chief Executive Officer and President of Orthofix, and Doug Rice, Chief Financial Officer, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Orthofix.

 

Dated: February 26, 2018

 

 

 

 

 

/s/ BRADLEY R. MASON

 

 

 

 

 

 

Name: Bradley R. Mason

 

 

 

 

 

 

Title:   President and Chief Executive Officer

 

Dated: February 26, 2018

 

 

 

 

 

/s/ DOUG RICE

 

 

 

 

 

 

Name:  Doug Rice

 

 

 

 

 

 

Title:    Chief Financial Officer